Patents by Inventor Eric Browne

Eric Browne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid-in-liquid cooling system for electronic components
    Patent number: 12289861
    Abstract: A cooling system and method of cooling electronic components comprising a tank (or other vessel) in which a dielectric liquid cools low power electronic components within the tank, while a conductive liquid cools high power electronic components in the tank. The conductive liquid is supplied via a plurality of cooling modules, each arranged on or in proximity to a high power component. A cooling module arranged within the tank may enclose one or more of the electronic components in the tank using a fluid-tight seal.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: April 29, 2025
    Assignee: JetCool Technologies Inc.
    Inventors: Bernard Malouin, Jordan Mizerak, Eric Browne
  • Liquid-In-Liquid Cooling System for Electronic Components
    Publication number: 20230156959
    Abstract: A cooling system and method of cooling electronic components comprising a tank (or other vessel) in which a dielectric liquid cools low power electronic components within the tank, while a conductive liquid cools high power electronic components in the tank. The conductive liquid is supplied via a plurality of cooling modules, each arranged on or in proximity to a high power component. A cooling module arranged within the tank may enclose one or more of the electronic components in the tank using a fluid-tight seal.
    Type: Application
    Filed: November 10, 2022
    Publication date: May 18, 2023
    Applicant: Jetcool Technologies Inc.
    Inventors: Bernard Malouin, Jordan Mizerak, Eric Browne
  • Pharmaceutical dosage forms and compositions
    Publication number: 20070099931
    Abstract: The invention relates to, for example, novel formulations and methods for the delivery of 4-cyano-N-{(2R)—2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.
    Type: Application
    Filed: September 6, 2006
    Publication date: May 3, 2007
    Applicant: Wyeth
    Inventors: Krishnendu Ghosh, Arwinder Nagi, Xiaohong Pan, Melissa Lin, Leonid Linberg, Ping Cai, Eric Browne, Michel Bernatchez, Mark Lankau, Sangeeta Raje
  • Crystalline and amorphous 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride
    Publication number: 20070027162
    Abstract: The present invention is directed to crystal and amorphous forms of the 5-HT1A receptor antagonist 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride, as well as compositions thereof and methods of using the same.
    Type: Application
    Filed: February 27, 2006
    Publication date: February 1, 2007
    Applicant: Wyeth
    Inventors: Eric Browne, Michel Bernatchez, Mark Lankau, Abdolsamad Tadayon, Anthony Hadfield
  • Pharmaceutical dosage forms and compositions
    Publication number: 20050215561
    Abstract: This invention relates to, for example, novel formulations and methods for the delivery of 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.
    Type: Application
    Filed: March 17, 2005
    Publication date: September 29, 2005
    Inventors: Krishnendu Ghosh, Arwinder Nagi, Xiaohong Pan, Melissa Lin, Leonid Linberg, Ping Cai, Eric Browne, Michel Bernatchez, Mark Lankau